CARVAJAL N ET AL: "Consequences of mutations of metal ligands in human liver arginase I.", MOLECULAR BIOLOGY OF THE CELL, vol. 13, no. Supplement, November 2002 (2002-11), page 546A, XP009157032, & 42ND ANNUAL MEETING OF THE AMERICAN SOCIETY FOR CELL BIOLOGY; SAN FRANCISCO, CA, USA; DECEMBER 14-18, 2002 ISSN: 1059-1524 (B1)

CHENG P N M ET AL: "Remission of hepatocellular carcinoma with arginine depletion induced by systemic release of endogenous hepatic arginase due to transhepatic arterial embolisation, augmented by high-dose insulin: arginase as a potential drug candidate for hepatocellular carcinoma", CANCER LETTERS, NEW YORK, NY, US, vol. 224, no. 1, 16 June 2005 (2005-06-16) , pages 67-80, XP004904542, ISSN: 0304-3835 (B1)

Stone E. et al.: "Engineering Human Arginase I as a Novel Cancer Therapeutic Agent", , 18 January 2009 (2009-01-18), XP002675137, Retrieved from the Internet: URL:http://aiche.confex.com/aiche/09icbe/p reliminaryprogram/abstract_143378.htm [retrieved on 2012-02-29] (B1)

NELSON CARVAJAL ET AL: "Interaction of arginase with metal ions: studies of the enzyme from human liver and comparison with other arginases", COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY PART B: BIOCHEMISTRY AND MOLECULAR BIOLOGY, vol. 112, no. 1, 1 September 1995 (1995-09-01), pages 153-159, XP055413141, AMSTERDAM, NL ISSN: 1096-4959, DOI: 10.1016/0305-0491(95)00027-6 (B1)

REHNER G ET AL: "EFFECT OF MANGANESE COBALT AND NICKEL ON THE ACTIVITY OF LIVER ARGINASE IN-VITRO AND IN-VIVO", MEDIZIN UND ERNAEHRUNG, vol. 11, no. 2, 1970, pages 32-35, XP009158520, (B1)

DAVID E ASH: "Structure and Function of Arginases", THE JOURNAL OF NUTRITION, AMERICAN SOCIETY FOR NUTRITION, US, vol. 134, no. 10, 1 October 2004 (2004-10-01), pages 2760S-2764S, XP008146967, ISSN: 0022-3166 (B1)